Medtronic Clinical Trial Gets FDA Approval to Evaluate CoreValve System

Medtronic, Inc., Friday announced U.S. Food and Drug Administration conditional approval for its Investigational Device Exemption application and pivotal clinical trial protocol to begin evaluating the Medtronic CoreValve System for transcatheter aortic valve implantation (TAVI).
TradingMarkets